Logo image
Quantitative Imaging Analysis of FDG PET/CT Imaging for Detection of Central Neurolymphomatosis in a Case of Recurrent Diffuse B-Cell Lymphoma
Journal article   Open access   Peer reviewed

Quantitative Imaging Analysis of FDG PET/CT Imaging for Detection of Central Neurolymphomatosis in a Case of Recurrent Diffuse B-Cell Lymphoma

Faiq Shaikh, Derek Savells, Omer Awan, Faisal Inayat, Ammar Chaudhry, Nivedita Jerath and Michael M Graham
Curēus (Palo Alto, CA), Vol.7(11), p.e379
11/13/2015
DOI: 10.7759/cureus.379
PMCID: PMC4689559
PMID: 26719822
url
https://doi.org/10.7759/cureus.379View
Published (Version of record) Open Access

Abstract

Neurolymphomatosis (NL) is a rare disease characterized by malignant lymphocytes infiltrating various structures of the nervous system. It typically manifests as a neuropathy involving the peripheral nerves, nerve roots, plexuses, or cranial nerves. It often presents as a complication of lymphoma, but it can be the presenting feature of recurrent lymphoma. It is essential to identify and initiate treatment early with chemotherapy and/or radiation therapy in all cases of nodal or visceral (including neural) involvement with lymphoma. There are various diagnostic tests that can be used for its detection, such as cerebrospinal spinal fluid (CSF) cytology, electromyography (EMG), magnetic resonance imaging (MRI), and positron-emission tomography/computed tomography (PET/CT). FDG-PET/CT is the standard of care in lymphoma staging, restaging, and therapy response assessment, but has an inherent limitation in the detection of disease involvement in the central nervous system. While that is mostly true for visual assessment, there are quantitative methods to measure variation in the metabolic activity in the brain, which in turn helps detect the occurrence of neurolymphomatosis.
analysis diffuse large b-cell lymphoma (dlbcl) fdg pet Neurology neurolymphomatosis Oncology pneuro quantitative Radiology

Details

Metrics

11 Record Views
Logo image